Search results
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 2 hours agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 1 day agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
Guru Focus· 12 hours agoStrengths highlight Pfizer's robust product portfolio and global market presence.Weaknesses underscore the challenges in revenue fluctuations and patent expira
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 2 days agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 hours agoSome corporations are condemned to deliver subpar financial results and stock market performances practically in perpetuity. Thankfully, Bristol Myers...
Pfizer whistleblower shares chilling video: ‘Tired of feeling like I have no hope…but I am NOT...
BizPac Review· 1 day agoA woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant. In addition, she’s published an ominous video declaring ...
Analyst Report: Pfizer Inc.
Argus Research via Yahoo Finance· 6 hours agoPfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs, treatments for rare diseases, and vaccines.
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga via Yahoo Finance· 2 days agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
